Sameet Chavan of Angel Broking told CNBC-TV18, "Sun Pharmaceutical Industries' chart structure certainly looks good. Overall with a broader view, it is in a consolidation mode, but within this congestion zone, we are seeing some signs of strength. After a consolidation of nearly three to four days in a small band, the stock has given a decisive breakout beyond resistance zone of Rs 900 with a rise in volumes. So, this clearly indicates that the stock is likely to climb towards Rs 940-950 over the next few trading sessions.""We have a buy on Sun Pharma keeping a stop loss of Rs 872 and one can buy this counter on any dip," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
